Global Pentosan polysulfate sodium Market will propel to garner USD 354.96 Mn, with a CAGR of 5.3% by 2025
05 June 2018
Pentosan polysulfate sodium is a semi-synthetically produced heparin-like macromolecular carbohydrate derivative, which chemically and structurally resembles glycosaminoglycans. It is a white odorless powder, slightly hygroscopic and soluble in water to 50% at pH 6. It has a molecular weight of 4000 to 6000 Dalton. Pentosan polysulfate sodium has anticoagulant and fibrinolytic effects.
Pentosan polysulphate sodium has an anticoagulant, fibrinolytic and thrombolytic quality with comparatively limited side effects.The global Pentosan polysulfate sodium market is segmented into application and regional segments. Anticoagulant, interstitial cystitis, osteoarthritis, transmissible spongiform encephalopathies and others are the applications covered under this study. The benefits of pentosan polysulfate sodium such as increasing usage in interstitial cystitis treatment, is expected to drive the pentosan polysulfate sodium market. Currently pentosan polysulfate sodium and dimethyl sulfoxide are two approved treatment options for interstitial cystitis. Thus, the limited treatment options and increasing incidences of interstitial cystitis is expected to drive the pentosan polysulfate sodium market during the forecast period. The regional concentration in usage of pentosan polysulfate sodium coupled with decreasing usage in last few years is a point of concern and challenge for major manufacturers of pentosan polysulfate sodium.
In terms of volume, global pentosan polysulfate sodium market in 2017 stood at 46.12 tons and is expected to reach around 60 tons by 2025 growing at a CAGR of 4.5% from 2018 to 2025. In terms of revenue, global pentosan polysulfate sodium market in 2017 stood at USD 260.98 Mn and is expected to reach USD 354.96 Mn by 2025 growing at a CAGR of 5.3% from 2018 to 2025. Interstitial cystitis application is the largest application segment of the pentosan polysulfate sodium market and it accounted for approximately 46% share of the total market in terms of revenue. Osteoarthritis application is expected to grow at a fastest growth rate of 5.9% during the time period of 2018 to 2025.
North America dominated the global pentosan polysulfate sodium market due to the large number of customers and huge demand in the region. In addition, high production of pentosan polysulfate sodium in North America helps to grow the market in coming years. Europe was the second largest market followed by Asia Pacific. Asia Pacific and South America are expected to grow at fastest growth rate during the forecast period.
Bene Pharmachem, Cf Pharma, Swati Spentose, Alembic, Janssen Pharmaceuticals, Inc., Molclone Labs Pvt. Ltd. , WisMed Pharma, Jigs chemical are some leading vendors of this market.
The Global Pentosan Polysulfate Sodium market is segmented as follows:
Global Pentosan Polysulfate Sodium Market: Application Analysis
Transmissible spongiform encephalopathies
Global Pentosan Polysulfate Sodium Market: Region Analysis